HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target.

AbstractPURPOSE:
To analyse the influence of cancer-associated stroma on FDG-uptake in two carcinoma models characterized by different stromal degrees.
METHODS:
Eight nude mice were subcutaneously injected with DU-145 prostate cancer cells or BXPC-3 pancreatic cancer cells, and underwent FDG-PET imaging about 2 weeks after implantation. After the mice were killed, histology, and CD31 and GLUT1 immunohistochemistry were performed. To further evaluate the highly stromalized carcinoma using perfusion-sensitive imaging, four BXPC-3 tumours underwent two successive albumin-binding (MS-325) MRI scans during tumour growth.
RESULTS:
FDG uptake was significantly higher in the DU-145 than in the BXPC-3 tumours, which were hardly distinguishable from adjacent normal tissue. In the BXPC-3 tumours, histology confirmed the widespread presence of aberrant infiltrated stroma, embedded with numerous vessels marked by CD31. In both tumour types, the stromal matrix was negative for GLUT1. In DU-145 tumour cells, GLUT1 immunostaining was greater than in BXPC-3 tumour cells, but not homogeneously, since it was less evident in the tumour cells which were nearer to vessels and stroma. Finally, MS-325 MRI always clearly showed areas of enhancement in the BXPC-3 tumours.
CONCLUSION:
Cancer-associated stroma has been reported to be capable of aerobic metabolism with low glucose consumption. Furthermore, it has been proposed that regions with high vascular perfusion exhibit a significantly lower FDG uptake, suggesting some vascular/metabolic reciprocity. Since our results are consistent with these recent findings, they signal a risk of tumour volume underestimation in radiotherapy if FDG uptake alone is used for target delineation of carcinomas, which suggests that additional evaluation should be performed using vasculature/perfusion-sensitive imaging.
AuthorsPaolo Farace, Daniela D'Ambrosio, Flavia Merigo, Mirco Galiè, Cristina Nanni, Antonello Spinelli, Stefano Fanti, Anna Degrassi, Andrea Sbarbati, Domenico Rubello, Pasquina Marzola
JournalEuropean journal of nuclear medicine and molecular imaging (Eur J Nucl Med Mol Imaging) Vol. 36 Issue 4 Pg. 616-23 (Apr 2009) ISSN: 1619-7089 [Electronic] Germany
PMID19093111 (Publication Type: Journal Article)
Chemical References
  • Glucose Transporter Type 1
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Radiopharmaceuticals
  • Slc2a1 protein, mouse
  • Fluorodeoxyglucose F18
Topics
  • Animals
  • Carcinoma (diagnosis, diagnostic imaging)
  • Cell Line, Tumor
  • Fluorodeoxyglucose F18 (pharmacology)
  • Glucose Transporter Type 1 (biosynthesis)
  • Homozygote
  • Humans
  • Image Processing, Computer-Assisted
  • Immunohistochemistry (methods)
  • Mice
  • Mice, Nude
  • Neoplasms (diagnosis, diagnostic imaging)
  • Platelet Endothelial Cell Adhesion Molecule-1 (biosynthesis)
  • Positron-Emission Tomography (methods)
  • Radiography
  • Radiopharmaceuticals (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: